NCT02970006

Brief Summary

The study hypothesis is that spinal cord stimulation (SCS) combined with virtual leg illumination (provided through a wearable headset (OculusRift, OculusVR, Irvine, CA) and a custom-designed virtual reality leg scenario) will lead to controlled analgesia induction, boosting analgesic effects obtained with standard SCS treatments and will further be associated with changes in the perception of the affected body part.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2016

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2016

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

November 16, 2016

Completed
5 days until next milestone

First Posted

Study publicly available on registry

November 21, 2016

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2018

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2019

Completed
1.9 years until next milestone

Results Posted

Study results publicly available

September 20, 2021

Completed
Last Updated

September 20, 2021

Status Verified

August 1, 2021

Enrollment Period

2 years

First QC Date

November 16, 2016

Results QC Date

December 3, 2019

Last Update Submit

August 23, 2021

Conditions

Keywords

spinal cord stimulationvirtual realityfull body illusion

Outcome Measures

Primary Outcomes (1)

  • Average Pain Reduction Post Intervention

    10 point Visual Analog pain rating Scale. Subjective pain perception will be measured by pain ratings on a 10cm visual continuous analog scale (VAS). Patients rate their pain, ranging from "no pain" (bottom part of the scale) to "the worst imaginable pain" (upper part of the scale) (Huskisson 1974). The pain reduction will be an average total of the pain scores taken at hours 1, 2, 3, 4, and 5.

    At each hour from 1-5 hours post intervention

Secondary Outcomes (1)

  • Pain Reduction Base on Patient Perception

    per minute in each virtual reality condition for 10 minutes in each reality condition.

Study Arms (1)

neurovisual stimulation

EXPERIMENTAL

Participants in this study will be adults who have already undergone implantation of SCS for the treatment of their pain conditions. The study involves no further treatment or intervention. Subjects will be approached for participation in this study during their routine postoperative clinical visit to the Center for Neuromodulation at the Ohio State University (OSU).All eligible patients will undergo a one-day visit for the virtual reality and full body illusion intervention. This research will also investigate leg embodiment and leg analgesic effects during SCS integrated with different patterns of virtual leg illumination.

Device: neurovisual stimulation

Interventions

a new system of multisensory stimulation based on virtual and enhanced reality (i.e., neuro-visual stimulation)

neurovisual stimulation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18-and older at the time of enrollment
  • Patients carrying a diagnosis of CPRS type 125 or chronic refractory neuropathic leg pain following FBS4
  • Patients who have implanted epidural SCS
  • The SCS implantation for at least three months prior to enrollment
  • Patients with efficacious SCS as defined by ≥ 50% pain improvement after switching SCS from an OFF state to an ON state ('optimal' stimulation efficacy)
  • Patients willing and able to provide informed consent

You may not qualify if:

  • Patients who are unable to effectively or efficiently communicate for example patients suffering from speech deficits (dysarthria, aphasia) or are non-English speaking.
  • Patients with history of prior cranial surgery, significant brain lesions for example intracranial tumors, strokes etc.
  • Non efficacious response to SCS \<50% pain improvement with optimal stimulation parameters
  • Evidence of untreated psychiatric disorders or drugs/alcohol abuse.
  • History of seizures

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Ohio Sate University

Columbus, Ohio, 43210, United States

Location

Related Publications (1)

  • Solca M, Krishna V, Young N, Deogaonkar M, Herbelin B, Orepic P, Mange R, Rognini G, Serino A, Rezai A, Blanke O. Enhancing analgesic spinal cord stimulation for chronic pain with personalized immersive virtual reality. Pain. 2021 Jun 1;162(6):1641-1649. doi: 10.1097/j.pain.0000000000002160.

MeSH Terms

Conditions

Neuritis

Condition Hierarchy (Ancestors)

Peripheral Nervous System DiseasesNeuromuscular DiseasesNervous System Diseases

Results Point of Contact

Title
Vibhor Krishna, MD
Organization
The Ohio State University- Neurological Institute

Study Officials

  • Vibhor R Krishna, MBBS

    Ohio State University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Clinical Professor

Study Record Dates

First Submitted

November 16, 2016

First Posted

November 21, 2016

Study Start

October 1, 2016

Primary Completion

October 1, 2018

Study Completion

November 1, 2019

Last Updated

September 20, 2021

Results First Posted

September 20, 2021

Record last verified: 2021-08

Data Sharing

IPD Sharing
Will not share

Locations